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Abstract. Recent clinical studies have shown that HIV disease pathogenesis
can depend strongly on many factors at the time of transmission, including
the strength of the initial viral load and the local availability of CD4+ T-cells.
In this article, a new within-host model of HIV infection that incorporates
the homeostatic proliferation of T-cells is formulated and analyzed. Due to
the effects of this biological process, the influence of initial conditions on the
proliferation of HIV infection is further elucidated. The identifiability of pa-
rameters within the model is investigated and a local stability analysis, which
displays additional complexity in comparison to previous models, is conducted.
The current study extends previous theoretical and computational work on the
early stages of the disease and leads to interesting nonlinear dynamics, includ-
ing a parameter region featuring bistability of infectious and viral clearance
equilibria and the appearance of a Hopf bifurcation within biologically rele-
vant parameter regimes.
1. Introduction. Mathematical modeling of the in-host behavior of viral infec-
tions has become an indispensable tool to biological researchers in recent decades.
New models have been used to describe the dynamical behavior of various infectious
diseases such as HIV, HBV, and influenza, among others. Within this field, test-
ing specific hypotheses based on clinical data is often difficult since samples cannot
be taken frequently from patients, and viral load detection techniques may lack a
necessary level of precision. Thus, new predictive models play a central role and
are continually needed to further our understanding of disease dynamics. One such
mathematical model that has been quite useful, known as the standard model of vi-
ral dynamics [23,26,27], describes the early stage in-host behavior of HIV infection.
In general, the time course of this disease typically consists of three distinct phases.
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The first, known as the acute stage, is characterized by a rapid fluctuation in both
the healthy T-cell and virion populations, usually lasting from 2 to 10 weeks [13].
Symptoms during this stage, often described as “flu-like”, include fever, swollen
glands, sore throat, rash, and fatigue. During the second stage, known as chronic
infection, the size of the uninfected T-cell population and viral load maintain rel-
atively constant states, with the latter known as the viral set point. Without the
aid of antiretroviral treatment, this period can persist for up to 10 years but can
vary greatly among individual patients [9,24,29]. Finally, within the third stage the
viral load experiences exponential growth with a correspondingly rapid decrease in
the healthy T-cell population. This leads to the onset of AIDS, defined clinically as
a T-cell count of an HIV-positive patient measured below 200 cells/mm3.
While the standard model of viral dynamics has been extremely successful in
reproducing the acute and chronic stages, it has been shown that both the infected
and infection-free equilibrium states of healthy T-cells, infected T-cells, and virions
induced by this model are globally asymptotically stable. This property was first
investigated analytically in [5], and later proved using a Lyapunov function in [18].
The global stability of these states implies that the long time asymptotic behav-
ior of the system depends only upon parameter values in the model. As a direct
consequence, both the equilibrium values and stability properties of these equilibria
are independent of initial conditions. However, a number of recent clinical stud-
ies [7, 14, 15, 19] have shown that additional factors beyond these parameters may
have a significant impact on the development or clearance of a persistent infection.
Such factors include the initial viral load and the availability of target CD4 T-cells
at the time of transmission. Because early events during infection may determine
both the pathogenic consequences of the virus and its sensitivity to interventions
or treatment strategies to combat the disease, Igarashi et al. [14] evaluated the ef-
fects of inoculum size on the development of the disease in macaques infected with
Simian/Human Immunodeficiency Virus (SHIV). In particular, the results of this
study showed that macaques who were administered large intravenous SHIV inoc-
ula experienced irreversible CD4+ T lymphocyte depletion and developed clinical
disease. In contrast, rhesus monkeys receiving 50% tissue culture infective doses
(or less) of virus survived the acute stage with reduced but stable levels of CD4+
T lymphocytes and produced antibodies capable of neutralizing SHIV. In short,
although SHIV induced an extremely rapid and profound depletion of T-cells in
all infected rhesus monkeys, the loss of this T-cell subset was not irreversible in
animals inoculated with small amounts of virus. A similar investigation has since
been conducted in [19] yielding analogous results.
A different study [15] has highlighted the importance of the T-cell count at the
time of primary viral infection. In particular, during further studies of seventeen
rhesus macaques, SHIV infection was found to emerge only in a single monkey whose
T-cell count had been markedly depleted by monoclonal antibody (mAb) treatment
at the time of primary viral infection, while none of the remaining sixteen monkeys
inoculated with SHIV, but not treated with the mAb, developed immunodeficiency.
A similar outcome was observed in [7]. Hence, the availability of target T-cells at
the time of viral transmission can also play a large role in the establishment of a
persistent infection, as differing strengths of the susceptible T-cell population may
promote or inhibit viral replication.
Since the equilibria of the standard model of viral dynamics are globally stable in
mutually exclusive parameter regimes, these empirical results suggest that, in order
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to appropriately describe early HIV (or SHIV) dynamics, additional factors must
be considered in the model development. Other authors [1, 3, 6, 10] have further
posited such considerations, asserting the need for a variety of secondary biological
characteristics including variability of host susceptibility to initial infection, within-
host competition between different viruses for target cells at the initial site of virus
replication, and the effects of the innate immune response. These ingredients should
play a realistic role in disease pathogenesis and long time dynamics. In general,
previous in-host models do not account for effects arising from the strength of the
initial viral load or variations in the T-cell count at the time of transmission, as they
describe the tendency to viral infection or clearance based solely upon parameters
and not on initial conditions.
Another element of disease pathogenesis overlooked within the standard model is
the homeostatic mechanism that regulates the peripheral T-cell pool. Recent clini-
cal studies have displayed the importance that homeostasis of the susceptible T-cell
population may play during infection [4, 22], as the replenishment of target cells
provides additional opportunities for HIV infection by freely moving virions. In the
current study, we focus on the homeostatic proliferation of T-cells, i.e. the process
by which T-cells in a lymphopenic host divide in the absence of cognate antigen to
reconstitute the peripheral lymphoid compartment, which is believed to be driven
by the presence of foreign antigens [20,31]. A few long-term models of HIV infection
[12,13,25] have incorporated the homeostatic proliferation of the T-cell population
within their formulation, but the dynamical effects of this biological mechanism are
not well-understood. Other authors [8] have considered an acute stage model incor-
porating a logistic growth term, depending only upon healthy T-cells, to represent
the body’s propensity to regulate the T-cell population. However, in the setting of
HIV-induced lymphopenia, it was determined [4] that the homeostatic proliferation
of CD4+ T-cells is driven primarily in response to the viral load, while naive CD4+
T-cells are also recruited into the proliferating pool due to CD4+ T-cell depletion.
Therefore, in the presence of HIV, such a regulatory mechanism should depend on
the strength of the viral load in addition to the size of the T-cell pool.
Based on the aforementioned experimental findings concerning the influence of
initial conditions and T-cell homeostasis, we explore a refined model of early stage
infection dynamics that incorporates the ability of the immune system to maintain
the T-cell count even when the number of such cells is depleted by the presence
of the virus. In accounting for such effects, it will be shown that this model will
accurately portray the dependence of equilibria on initial conditions by producing
a biologically relevant parameter regime featuring bistability of the infected and
uninfected equilibrium states. Hence, the model proposed herein will account for
both of the aforementioned processes. In the next section, the new model of early
HIV infection is discussed, and a study of parameter identifiability is conducted. In
Section 3, we prove that exactly three states exist - one uninfected and two infected
equilibria. In Section 4, the local stability properties of equilibria are characterized
in terms of parameter values. In particular, we identify a biologically-important
region of the parameter space within which both the relevant infected equilibrium
and the viral clearance state are locally stable. This illustrates that the development
of a persistent infection will depend crucially on initial conditions, and we further
explore the basins of attraction generated by these equilibria. Finally, we show that
the system experiences a Hopf bifurcation that gives rise to oscillatory behavior
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within a certain parameter regime. To conclude the paper, appendices containing
proofs of the aforementioned results are provided.
2. Model and Parameters. The proposed dynamical model couples a nonlinear
system of three ordinary differential equations given by
dT
dt
= λ+
ρ
C + V
TV − kTV − dTT
dI
dt
= kTV − dII
dV
dt
= pI − dV V.


(3CM)
Here, T (t) denotes the population of healthy T-cells, I(t) the population of these
cells which have been infected, and V (t) the size of the virion population. The
parameter λ represents the source of new cells arising from general production,
while the healthy cell death rate is denoted by dT . The interaction, or mass action,
term kTV , where k is the infection rate, represents the infection of healthy T-
cells and the subsequent conversion of these cells to infected lymphocytes, with
corresponding death rate dI . The parameter p is the rate at which new virions are
created by the infected cell population, and the clearance rate of free virus particles
is given by dV . See Table 1 for a complete list of parameters and variables with
representative initial values. Additionally, in this model we do not consider distinct
compartments within the host since the dynamics of interest take place over many
weeks, while transfer between these compartments occurs on the time scale of hours.
The term ρ
C+V TV describes the homeostatic production of T-cells due to the
presence of the virus and subsequent decline in healthy T-cells, both of which may
vary over the course of infection. Here, ρ is the maximum growth rate and C
is the half-velocity constant of growth. Note that the behavior of this term is
limited by the growth and decay of the virus population. In particular, the function
M(V ) = ρV
C+V satisfies M(0) = 0, M
′(V ) > 0 and lim
V→∞
M(V ) = ρ. Hence, when
no virions are present in the system, this so-called Michaelis-Menten term vanishes
and the basic dynamics are the same as the standard virus model. This is consistent
with the actual immune response as the body need not further augment the T-cell
population in the absence of virions. Contrastingly, as the virus population grows
large, the infected host’s immune system replenishes the T-cell population so as to
balance the effects resulting from its depletion, and this occurs at a growing rate
whose maximal impact is ρT . Regardless of the limited rate of growth within this
term, the inclusion of homeostatic proliferation, as we will show, has a profound
affect on the dynamics of the system.
While the new model (3CM) can be derived from a bottom-up approach merely
by adding the homeostatic proliferation term to the standard model of viral dynam-
ics, it also stems directly from a top-down approach. More specifically, (3CM) can
be fully derived from a reduced description of long-term models that were proposed
in [12, 13] to accurately represent all three stages of HIV infection within a host.
In particular, a dynamic active subspace decomposition of the twenty-seven dimen-
sional parameter space within the three-stage model of [12], which features seven
different in-host populations, was performed in [25]. This decomposition produces a
global sensitivity analysis of the parameter space and indicates exactly which param-
eters are important to the evolution of the model during each of the three distinct
phases of disease progression. Upon eliminating those parameters (of which there
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Quantity Values / Initial Values References
Original Populations
T Uninfected CD4+ T-cells 1000 mm−3 [13]
I Infected CD4+ T-cells 0 mm−3 [13]
V Wild-type HIV virions 10−2 mm−3 [13]
Dimensionless Populations (∗ omitted in exposition)
T ∗ = pk
dIdV
T T ∗0 = 1.81
I∗ = pk
dT dV
I I∗0 = 0
V ∗ = k
dT
V V ∗0 = 4.57 × 10−5
t∗ = dT t
Original Parameters
λ Rate of supply of T-cells 10 mm−3 day−1 [17]
ρ Maximum homeostatic growth rate 0.01 day−1 [13]
C Homeostatic half-velocity 300 copies mm−3 [13]
k Infection rate 4.57× 10−5 mm3 day−1 [12, 13]
dT Death rate of uninfected T-cells 0.01 day
−1 [12, 13]
dI Death rate of infected T-cells 0.40 day
−1 [13, 17]
p Rate of viral production 38 virions per cell day−1 [12, 13]
dV Clearance rate of free virus 2.4 day
−1 [12, 13]
Dimensionless Parameters
R0 =
λkp
dT dIdV
1.81
Rm =
ρ
Ck
0.73
α1 =
dI
dT
40
α2 =
dV
dT
240
β = dT
Ck
0.73
Table 1. Variables and Parameters
were nineteen) that are found to be negligible throughout the acute stage, a total
of four populations - namely the influence of latently-infected T-cells, macrophages,
infected macrophages, and the cytotoxic lymphocyte response - completely decou-
ple from the model. Hence, the reduced system (3CM) results, providing a more
precise description of the early stage behavior of the disease than the standard vi-
ral dynamics model. Figure 1 contains a representative simulation of (3CM) and
includes a comparison to the early stage behavior of the long-term model of [12].
We note that other models of HIV infection [2, 13, 30] have also incorporated such
a Michaelis-Menten term to describe homeostasis, though the current article will
contain the first dynamical analysis of such a model.
2.1. Dimensionless system. To reduce the size of the parameter space, the orig-
inal model (3CM) is recast in dimensionless form. The resulting system, in which
dimensionless populations have been renamed T ∗, I∗, and V ∗ is
dT ∗
dt
= R0 +
Rm
1 + βV ∗
T ∗V ∗ − T ∗V ∗ − T ∗
dI∗
dt
= α1 (T
∗V ∗ − I∗)
dV ∗
dt
= α2(I
∗ − V ∗).


(3CM*)
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Figure 1. A representative simulation of (3CM) with parameter values
given in Table 1, and a comparison with the full three-stage model in [12]
- T-cell count (left) and viral load (right).
where
R0 =
λkp
dT dIdV
, Rm =
ρ
Ck
, α1 =
dI
dT
, α2 =
dV
dT
, β =
dT
Ck
. (1)
The values of dimensionless parameters are summarized within Table 1, and in
the future we will remove the ∗ notation and deal solely with the dimensionless
system. Notice that each new parameter is positive since the original variables
are positive. The complete derivation of (3CM*) from (3CM) can be found in
Appendix A. The model (3CM*) contains only five parameters, and each may play
a role in the dynamics of the system. However, we will typically fix the values of
α1, α2, and β while considering variations in R0 and Rm, which represent the usual
basic reproduction number (as in the standard viral model) and a new reproduction
number generated by the addition of the Michaelis-Menten term, respectively.
2.2. Parameter Identifiability. With the dimensionless system determined, we
study parameter identifiability in (3CM*) as this model can provide useful simula-
tions only if the parameters involved can be discerned from data. In particular, we
first conduct a test of (3CM*) developed for differing models in [21], [32], and [33]
to understand the structural identifiability of parameters. Structural identifiability
is used to characterize the one-to-one property of the map that takes the parameter
space to the set of system outputs (i.e., the information encapsulated by collected
data). In order to evaluate this property for (3CM*) we use the so-called Multiple
Time Points (MTP) method developed in [32], which entails the construction of an
invertible identification function Φ(θ), from the parameter space to the set of ob-
servable outputs, that preserves the structure of the differential equations model. In
particular, because invertibility of such a mapping is required, we wish to ultimately
conclude that ∂Φ
∂θ
has full rank.
To begin, we first describe the space of output values. Because healthy and
infected T-cell counts can be both difficult to measure and unreliable, data is most
easily gathered from an individual’s viral load. Hence, model outputs in this context
will be regarded as values of the viral load and its derivatives, as the latter are
needed to compensate for the lack of T-cell data but can be generated from values
of V . Thus, we begin to construct Φ by first eliminating the populations T and I
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within (3CM*) in favor of derivatives of V . This procedure involves merely taking
derivatives in (3CM*) and representing T and I in terms of V˙ , V¨ , and
...
V and yields a
single equation to represent the original three-dimensional system of ODEs, namely
...
V − f(V, V˙ , V¨ , θ, t) = 0,
where f is given by (3) below and θ = (R0, Rm, α1, α2, β)
T is the vector of pa-
rameters. Hence, any solution of (3CM*) can be characterized by satisfying this
relationship at time t.
In order to identify the five distinct parameters in the model, five identification
equations are needed, and this requires us to satisfy the above ODE at five different
time points, say tk, for k = 1, ..., 5. Given this, we denote Vk = V (tk), with the
same notation for derivatives (e.g., V˙k = V˙ (tk)), and construct the identification
function Φ : R5 → R5 defined by
Φ(θ) =


...
V 1 − f(V1, V˙1, V¨1, θ, t1)...
V 2 − f(V2, V˙2, V¨2, θ, t2)
...
...
V 5 − f(V5, V˙5, V¨5, θ, t5)

 (2)
where
f(V, V˙ , V¨ , θ, t) = α1α2R0V +
(
Rm
1 + βV
− 1
)(
V¨ + α1V˙ + α2V˙ + α1α2V
)
V
+
(
V˙ − V − (α1 + α2)V
)(
V¨ + (α1 + α2)V˙ + α1α2V
) 1
V
+ α1α2(α1 + α2)
(
1
α2
V˙ + V
)
+ α22V˙ .
(3)
By construction, the model (3CM*) is trivially satisfied at fitted parameter values θ∗
given in Table 1 as Φ(θ∗) = 0, and we are thus interested in whether Φ is invertible
for values of θ ≈ θ∗.
Now, computation of Φ requires knowledge of V and its derivatives at five differ-
ent time points, but values for these derivatives are typically unavailable either as
collected data or via direct simulation of the model. Thus, we must require addi-
tional values of the viral load in order to compute them. In particular, eight values
of V are needed to numerically approximate
...
Vk for k = 1, ..., 5 by using a suitable
finite difference approximation. Therefore, we choose three additional time values
t6, t7, and t8 at which V must be known, and note that the values of V˙k, V¨k, and
...
Vk
for k = 1, ..., 5 are merely determined by values of the viral load at multiple time
points; for example,
...
Vk depends upon V1, ..., V8 for every k = 1, ..., 5.
In order to conclude that the model is locally structurally identifiable, we must
show that the corresponding Jacobian matrix ∂Φ
∂θ
is invertible near the fitted values
θ = θ∗. Since this is nearly impossible to perform analytically, we instead take
a computational approach. First, we symbolically represent the matrix ∂Φ
∂θ
using
(2) and (3). Then, fixing a specific vector of parameter values θ, we simulate the
output variable V (t; θ) at a chosen sequence of times using (3CM*) and Matlab’s
ode15s solver, and then numerically approximate its derivatives. Finally, we use
these simulated values of Vk, V˙k, V¨k, and
...
Vk to compute the resulting rank of the
Jacobian for these particular parameter values. Repeating this calculation over a
grid of parameter values within the biologically reasonable ranges [0.5θ∗k, 1.5θ
∗
k] for
k = 1, ..., 5, we find rank
(
∂Φ
∂θ
)
= 5 for every simulation. Thus, we conclude that ∂Φ
∂θ
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is of full rank and the associated parameters are structurally identifiable, at least
locally, in the range of parameter values used for these simulations.
While this analysis provides a theoretical assurance that parameter values can be
identified from exactly observed viral load data, clinical measurements will always
contain some level of error. Even a model such as (3CM*), in which parameters
can be uniquely identified locally within the parameter space, may yield unreliable
parameter estimates due to noisy fluctuations or measurement error in the data.
Hence, we also study the practical identifiability of parameters, namely the relative
proximity of fit parameters to their true values given uncertainty within obtained
data, by using a Monte Carlo method outlined within [21] and [32].
To estimate the differences in parameter fits generated from noisy data, we will
use a metric known as the average relative estimation error (ARE). Prior to pre-
cisely defining this quantity, we outline the algorithm for generating such values.
Beginning with the previously fit vector of parameters θ∗, we first use the numerical
ODE solver to generate a time course of baseline viral load values V ∗j = V (tj ; θ
∗)
for a chosen set of times tj , j = 1, ...,M . Next, we choose a sensitivity threshold
δ > 0 and a number of Monte Carlo trials N ∈ N, then define the perturbed viral
load data
Vˆ nj = V
∗
j + ǫ
n
j , j = 1, ...,M, n = 1, ..., N (4)
where ǫnj ∼ N(0, δ) represents an unbiased normally-distributed measurement error
for each fixed j and n. With random error introduced within the simulated data,
we perform N parameter fits of this data to generate N new vectors of parameter
values θˆn, for n = 1, ..., N . Finally, to evaluate the variations in these fits generated
by the noise, we define the ARE for each parameter by
AREδ,k =
1
N
N∑
n=1
|θˆnk − θ∗k|
|θ∗k|
· 100%, (5)
where θˆnk is the estimate of the kth parameter of θˆ
n arising from the nth perturbation
with variance δ. Hence, this Monte Carlo method simulates the introduction of
Gaussian measurement noise within the viral load data (4) based on the output
model (3CM*) and computes the expected response in parameter values from these
variations.
The ARE algorithm was applied to simulations of N = 1000 distinct simulated
noisy measurement sets for each δ noise level of 5, 10, 15, ..., 30 percent of the fit value
θ∗k, at time points t = 0, 1, 2, ..., 90. The results are summarized in Table 2. Hence,
we find a collection of small relative errors, with only the error in β rising above
δ% of the true value. That being said, β also displays relatively minor fluctuations
throughout the simulations, even for noisy data, and other parameters possess even
less deviation from their fit values. Thus, (3CM*) appears to be quite robust with
respect to variations in measurement data for the purposes of parameter fitting.
3. Steady States. We begin an analysis of the dynamics of (3CM*) by first deter-
mining all steady states and investigating their regions of biological relevance within
the parameter space. This information will be used extensively in the next section
in which the local dynamics of solutions is characterized. We first compute the
associated steady states, which are given in the form of an ordered triple (T, I, V )T .
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Noise level Calculated ARE in % of fitted value
δ in % α1 α2 β R0 Rm
5 2.6066 5.1185 8.5814 3.2080 4.1637
10 3.5020 6.6600 14.9092 4.7260 6.0953
15 4.2652 7.4536 20.0601 6.5109 8.0292
20 4.6269 8.5138 24.2512 7.7800 8.6645
25 5.2935 9.6199 27.6901 5.5697 9.7956
30 5.6840 9.9405 30.8474 9.9440 10.9832
Table 2. Calculated ARE of each parameter with N = 1000 trials.
Figure 2. Regions of existence (i.e. real and positive values) for the unin-
fected state, Eu, and infected states, E
+
i and E
−
i in the (Rm, R0) plane.
In particular, we find exactly three solutions to the algebraic system guaranteed by
R0 +
Rm
1 + βV
TV − TV − T = 0
α1 (TV − I) = 0
α2(I − V ) = 0


(6)
and they are summarized within the following theorem.
Theorem 3.1. The only time-independent solutions of (3CM*) are
Eu =


R0
0
0


E+
i
=


1
−b+
√
b2−4ac
2a
−b+
√
b2−4ac
2a


E−
i
=


1
−b−
√
b2−4ac
2a
−b−
√
b2−4ac
2a


where a, b, and c are defined by
a = β, b = 1−Rm + β(1 −R0), c = 1−R0
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and the dimensionless parameters are defined by (1).
Here, Eu is the uninfected steady state while E
+
i and E
−
i represent states of per-
sistent infection. In the future, when referring to components of equilibria, we will
use a bar to distinguish between the components of these states (e.g., V ) and time-
dependent solutions (e.g., V (t)). Additionally, we will distinguish amongst the same
components of different equilibria using subscripts (i.e., V u, V +, and V −). Since
all components represent scaled population sizes, we impose restrictions on the val-
ues for which these steady states are biologically reasonable. All three populations
of Eu will remain nonnegative for all times. However, for both E
+
i and E
−
i , we
must require that the infected T-cell population, I, and the virus population, V ,
be real and positive. To ensure real valued populations, we impose the restriction
b2 − 4ac ≥ 0, which is equivalent to the condition
R0 ≥ 1− 1
β
(1−
√
Rm)
2. (Ereal)
The requirement that all populations of the infected states be positive forces other
restrictions. For positivity of the E+i state, we must impose either
R0 > 1 +
1
β
(1 −Rm) (E+1 )
or the condition
1 < R0 ≤ 1 + 1
β
(1−Rm). (E+2 )
For all populations within the E−i state to remain positive, we must impose the
condition
1 +
1
β
(1−Rm) < R0 < 1. (E−)
These constraints are justified within Appendix B. Additionally, Figure 2 provides a
graphical summary of the restrictions on parameters necessary to guarantee positiv-
ity of corresponding equilibria. We will often refer to such a region as the “region of
existence” of an equilibrium state, and in studying equilibria, we will always assume
that parameters are within the region of existence of the state under consideration.
Clearly, these restrictions depend upon only three parameters - β, R0, and Rm.
However, because β does not greatly affect the qualitative structure of the system,
we will fix this parameter and focus on the behavior of the system depending only
upon R0 and Rm. A similar approach will be taken in the investigation of stabil-
ity properties of equilibria, which may further depend upon α1 and α2, but these
two additional parameters are ratios of death and clearance rates, which are fairly
well-known. Thus, we will later fix these parameters as well, and again focus on the
relationship between R0 and Rm.
4. Stability of Equilibria. Having established conditions guaranteeing their bi-
ological relevance, we next examine conditions which guarantee the local stability
of equilibria. To do so, we will utilize some standard dynamical tools such as
the Hartman-Grobman Theorem applied to the linearization of (3CM*) and the
Routh-Hurwitz criteria. The following result, the proof of which can be found in
Appendix C, provides precise conditions on the parameter space that yield local
stability and thus viral clearance or persistence.
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Figure 3. Regions of stability in the (Rm, R0) plane when α1, α2, β are
fixed to the values in Table 1.
Theorem 4.1. If R0 < 1 then the infection-free equilibrium Eu is locally asymptot-
ically stable, whereas if R0 > 1 then it is unstable. Additionally, for all parameter
values that guarantee the positivity of the components of E−i , this equilibrium is
unstable. Finally, let V + denote the value of the viral load for E
+
i , which can be
expressed in terms of β, R0, and Rm by Theorem 3.1. Then, the equilibrium E
+
i is
locally asymptotically stable if the condition
α1α2
1 + βV +
[
βV
2
+ +R0 − 1
]
< (α1 + α2)R0(α1 + α2 +R0) (7)
is satisfied, and otherwise unstable. These parameter regimes are summarized by
Figure 3.
In short, only the uninfected steady state, Eu, and the infected steady state,
E+i , are locally asymptotically stable within their respective biologically relevant
regions, as described by Figure 3. The (light) green region denotes the portion
of the (Rm, R0) plane in which Eu is locally asymptotically stable, while the area
that is shaded (dark) red denotes the corresponding local stability region for the
E+i state. Interestingly, there is a small overlap of these two regions in which
both steady states are locally stable, namely the striped triangular region. An
illustration of the change in the regions of Figure 3 generated by differing values of
β is provided in Figure 4. Finally, we note that with the original fitted parameter
values, the reproduction numbers are R0 = 1.53 and Rm = 0.923, respectively,
which corresponds to the development of a persistent viral infection.
4.1. Basins of Attraction in the Bistable Region. Since both steady states
are locally stable in the overlapping region of Figure 3, we expect that differing long-
term behavior, and hence different disease outcomes, may arise from variations in
initial data. Indeed, this is the case, and we demonstrate this by considering two
different simulations of the model with (Rm, R0) values within the bistable region.
In order to display population values on a biologically pertinent scale, simulation
values for T (t) and V (t) are referenced and displayed in the original, dimensional
variables, rather than for the dimensionless system.
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(a) β = 1
2
β∗ (b) β = β∗ (c) β = 2β∗
Figure 4. Changes to stability of equilibria given differing values of β where
β∗ = 0.73 is the fitted value for β in Table 1.
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Figure 5. Small changes in initial data, T0 (top) and V0 (bottom), yield
changes in asymptotic behavior within the bistable parameter region - T-cell
count (left) and viral load (right). Within both simulations, dimensionless
parameters are fixed to Rm = 0.6 and R0 = 3. Recall that V u ≡ 0 is the
equilibrium viral load for Eu, and note that V (t) is represented on a log scale.
Figure 5 demonstrates the bistability of equilibria in two different scenarios. The
first pair of simulations (Figure 5, top row) fixes parameter values (Rm = 0.6, R0 =
3) and the initial viral load (at V0 = V +), but varies the initial T-cell count.
For T0 ≈ 675 the viral clearance (Eu) state is stable, and for T0 ≈ 550 the viral
persistence (E+i ) state is stable. The top left plot shows T-cell count over time with
the analytical steady state T-cell values, Tu ≡ 330 and T+ ≡ 550, highlighted. The
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Figure 6. Simulation results for Rm, R0 values within the bistable region.
A simulation was conducted at each point in the displayed parameter space
with initial conditions T0 = 1, I0 = 0, V0 = V +, where V + is the equilibrium
viral load of the E+i infective equilibrium evaluated at (Rm, R0). Green dots
indicate solutions which tend toward the uninfected steady state Eu, while red
crosses indicate solutions tending to E+i , the infected steady state.
top right plot shows the progression of infection, with the steady state viral load
V + ≈ 455 highlighted (of course, V u ≡ 0). We note that the large-time behavior of
these solutions differs significantly even though the parameter values are identical
and initial data are quite similar; in fact, the initial viral load is the same.
Similarly, the second pair of simulations (Figure 5, bottom row) fixes parameter
values and the initial T-cell count (at T0 ≈ 550), with a varied initial viral load.
For V0 ≈ 393 the viral clearance (Eu) state is stable, and for V0 ≈ 455 the viral
persistence (E+i ) state is stable. Again, steady-state T-cell values - Tu ≡ 331 and
T+ ≡ 552 - are highlighted within the bottom-left figure, while V + ≡ 455, is shown
in the bottom-right figure, and V u ≡ 0 for the uninfected equilibrium. Again, the
large-time behavior of these solutions differs significantly even though all initial and
parameter values other than the initial viral load are equal.
To demonstrate this further, we simulate the progression of the model for varying
(Rm, R0) values with other dimensionless parameters held constant and test whether
the large-time behavior of these solutions tends towards the Eu or E
+
i steady state.
The results of these simulations over the bistable region is shown in Figure 6.
While these simulations provide information regarding the qualitative difference
between solutions in this parameter region, they fail to describe how close initial
data must be to equilibrium in order to guarantee their stability, i.e. the basin of
attraction. To study these basins of the two stable equilibrium states, we perform
a number of perturbative computational studies at differing points in the bistable
region. The results, shown in Figures 7 and 8, display the sensitivity to initial
conditions at each location. Notice that locations closer to R0 = 1 and further to
the right in the bistable region display a greater basin of attraction for E+i than
those to the left of this region in the (Rm, R0) plane, as displayed by Figures 8(c),
(e), and (f). The appearance of a strip of persistent infection steady states increases
while moving from left to right within this region. We see that the initial viral load
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Figure 7. The dependence of equilibria on initial values of healthy T-cells
and the initial viral load at arbitrary points in the (Rm, R0) plane. Corre-
sponding results are shown in Figure 8.
has a minor influence on the shape of the strip for various locations as the width
of each strip is not uniform, while the initial T-cell count has a more pronounced
affect on the long term behavior. As these initial values are dimensionless, when
T0 is rescaled to represent an actual T-cell count, the basins of attraction for the
infected steady state E+i are increased by a factor of nearly 10
3. Similarly, the
basin of attraction corresponding to perturbations in the viral load are increased
by around 200 when V0 is rescaled to represent a true viral load.
An individual infected with HIV typically possesses baseline parameters (see
Table 1) corresponding to a location in the (Rm, R0) plane lying above R0 = 1, and
hence within the E+i stability region. However, certain parameter values, including
the infection rate k and the rate of viral production p, are known to vary widely
amongst individuals, and thus the feasible region of attained values within the
(Rm, R0) plane is quite vast. In particular, k has been reported to be as small as
10−6 [13] and as large as 10−2 [12], and this uncertainty could allow the values of
Rm and R0 to vary within the range 10
−2− 102. Thus, we see that the biologically
feasible parameter regime extends even into the unshaded region of Figure 3, which
leads us to study the dynamics there, as well.
4.2. Hopf Bifurcation. From Figure 3, we notice that there is a region of the
parameter space within which no equilibrium point is locally stable. Thus, one
may expect that a different attracting set inherits this property for such parameter
values. Indeed, this is the case, and as we will show using Rm as a bifurcation
parameter, a Hopf bifurcation occurs at the boundary of this domain. In particular,
we will take any R0 > 1, vary Rm to move within this region of the (Rm, R0)
plane, and investigate the stability properties of E+i as they change along the right
boundary of the (dark) red region within Figure 3. Since Rm will be used to move
through the parameter space, we will alter notation when necessary in order to
denote certain quantities that depend on this parameter. As demonstrated within
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(d) Rm = 3, R0 = 0.55
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(e) Rm = 5, R0 = 0.55
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(f) Rm = 4, R0 = 0.2
Figure 8. Basins of attraction within the bistable region. For each
(R0, Rm) point, the initial T-cell count and viral load (both dimensionless)
were set to the E+
i
steady state evaluated at (R0, Rm). This forms the central
point in each plot, and then both initial conditions are shifted ±40%. Green
dots denote simulation convergence to Eu, and red crosses to E
+
i
. A visual
summary of the points chosen in the bistable region is provided by Figure 7.
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Appendix C, the Jacobian of system (3CM*) evaluated at E+i is
∇f(E+i ) =


−R0 0 Rm(1+βV +)2 − 1
α1V + −α1 α1
0 α2 −α2


where V + = V +(Rm) is the E
+
i viral population given by Theorem 3.1. Recall that
this steady state value satisfies the quadratic equation
βV
2
+ + [β(1−R0) + 1−Rm]V + + 1−R0 = 0 (8)
and thus varies with Rm when all other parameters are fixed. The characteristic
polynomial associated to ∇f(E+i ) is
η3 + d2η
2 + d1η + d0(Rm) = 0 (9)
where
d0(Rm) =
α1α2V +
(1 + βV +)2
[
(1 + βV +)
2 −Rm
]
,
d1 = (α1 + α2)R0,
d2 = α1 + α2 +R0.
Using (8), and in particular the relationship
(1−Rm)V + = −βV 2+ + (R0 − 1)(1 + βV +),
we can rewrite d0 as
d0(Rm) =
α1α2
1 + βV +
[
βV
2
+ +R0 − 1
]
. (10)
Notice that d1, d2 > 0 since all parameters are positive. Additionally, we establish
the following result, which will be useful in our study of the roots of (9) and in the
proof of Theorem 4.1.
Lemma 4.2. Within the region of existence of E+i , we have
βV
2
+ +R0 − 1 > 0
and thus d0(Rm) > 0 within this parameter region.
The proof of Lemma 4.2 is contained within Appendix B. Next, denote the corre-
sponding roots of the characteristic polynomial (9) by ηi(Rm), i = 1, 2, 3. It follows
that the mapping Rm → ηi(Rm) is smooth, as displayed within Figure 9. To begin
our study of the eigenvalues of this system, we first show the existence of a negative
real root within the local stability region of E+i .
Lemma 4.3. For any Rm > 0 within the region of existence for E
+
i , the charac-
teristic polynomial possesses at least one real, negative root. Additionally, all real
roots are negative.
Proof. By the Fundamental Theorem of Algebra, the above characteristic polyno-
mial will have exactly three roots. Thus, it will either possess one real root and two
complex roots, or three real roots. Using Lemma 4.2, we find d0, d1, d2 > 0 in the
region of existence for E+i , and thus any real root must be negative. Hence, the
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Figure 9. Real and imaginary parts of eigenvalues η2 and η3 as functions
of the bifurcation parameter Rm with R0 = 1.25 fixed. These curves cross the
imaginary axis at Rm = R∗m ≈ 9 when using parameter values from Table 1.
characteristic polynomial has either three negative real roots or one negative real
root and two complex conjugate roots. In either case, the conclusions follow.
Next, we define
D2(Rm) = d1d2 − d0(Rm)
to be the second Hurwitz determinant of the characteristic polynomial (9). Further,
for a fixed value of R0 > 1, let R
∗
m be the value of Rm in the region of existence of
E+i such that D2(R
∗
m) = 0. We will see that the curve D2(Rm) = 0 corresponds to
the right edge of the E+i stability region in Figure 3. The following result shows that
as the value of Rm is increased beyond R
∗
m, so that the point (Rm, R0) lies outside
of the E+i stability region, the complex eigenvalues become purely imaginary.
Lemma 4.4. At the point Rm = R
∗
m, two eigenvalues of ∇f(E+i ), denoted η2(R∗m)
and η3(R
∗
m), are purely imaginary and conjugate, while the third, η1(R
∗
m), is real
and negative.
Proof. At the value Rm = R
∗
m, we have D2(R
∗
m) = 0 and thus d0(R
∗
m) = d1d2.
Therefore, (9) can be written as
η3 + d2η
2 + d1η + d1d2 = 0
or
(η2 + d1)(η + d2) = 0,
which possess the roots
η1 = −d2 = −(α1 + α2 +R0)
η2 = i
√
d1 = i
√
(α1 + α2)R0
η3 = −i
√
d1 = −i
√
(α1 + α2)R0.
Finally, with this understanding of η1, η2, and η3, we can prove the existence of
a Hopf bifurcation across the curve D2(Rm) = 0.
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Theorem 4.5. For R0 > 1, a Hopf bifurcation occurs at the critical value Rm =
R∗m. In particular, as the value of Rm crosses R
∗
m, the equilibrium point E
+
i becomes
unstable and a stable limit cycle branches from the equilibrium.
Proof. With Lemmas 4.3 and 4.4, we need only show the transversality condition,
dη2
dRm
(R∗m) 6= 0 to prove the existence of a Hopf bifurcation. Using the characteristic
polynomial (9) evaluated at η2(Rm), we take the Rm-derivative to find
dη2
dRm
[
3η22 + 2d2η2 + d1
]
+ d′0(Rm) = 0
which yields
dη2
dRm
(Rm) = − d
′
0(Rm)
3η22 + 2d2η2 + d1
.
Evaluating the derivative at Rm = R
∗
m and substituting the known value for
η2(R
∗
m) = i
√
d1 this becomes
dη2
dRm
(R∗m) =
−d′0(R∗m)
−2d1 + 2id2
√
d1
.
Thus, multiplying by the conjugate and taking the real part, we find
Re
(
dη2
dRm
(R∗m)
)
=
d′0(R
∗
m)
2[d1 + d22]
.
From this, it follows that Re
(
dη2
dRm
(R∗m)
)
6= 0 if and only if d′0(R∗m) 6= 0. Using
(10), we compute this term as
d′0(Rm) =
β
1 + βV +
[−d0(Rm) + 2α1α2V +] dV +
dRm
.
Now, using (8) we compute dV +
dRm
so that
2βV
dV +
dRm
− V + + [β(1−R0) + 1−Rm] dV +
dRm
= 0,
and after some algebra and use of (8), this implies
dV +
dRm
=
V +
2βV + + β(1 −R0) + 1−Rm
=
V
2
+
βV
2
+ +R0 − 1
.
Since V + > 0 for R0 > 1, we conclude that this term is strictly positive. Finally, a
brief computation using (10) shows that the remaining term in d′0(Rm) satisfies
−d0(Rm) + 2α1α2V + = α1α2V +
1 + βV +
[Rm + 1 + β(R0 − 1)] .
Since R0 > 1 and V + > 0, this term is strictly positive, as well. Hence, we find
d′0(R
∗
m) 6= 0 and the proof is complete.
To supplement these analytical results, we also include representative simulations
of the system for specific values of R0 > 1 near the point Rm = R
∗
m within Figures
10 - 12. In particular, Figure 10 demonstrates the stability of the infected steady
state within the region in which only Ei
+ is locally asymptotically stable. In such
a case (R0 = 1.25, Rm = 6.5 here), the complex eigenvalues of the Jacobian matrix
evaluated at Ei
+ possess negative real part, and Figure 10(a) displays the dynamics
of the corresponding solution spiraling inward toward the E+i equilibrium. In Figure
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Figure 10. Simulation of the dimensionless system for Rm = 6.5 and R0 =
1.25. The parameter location is in the (dark) red region of Figure 3. Hence,
complex eigenvalues of the system linearized about E+i are of the form α± iβ
where α < 0, yielding a stable steady state. Green and red horizontal lines
indicate corresponding population values of the E+i and Eu steady states,
respectively.
11, the bifurcation parameter Rm is adjusted so that Rm ≈ R∗m and the location in
the parameter plane is at the border of the region of E+i stability and the unshaded
region seen within Figure 3. The associated complex eigenvalues now have real parts
which approach zero, and the emergence of a periodic orbit in Figure 11(a) becomes
more visible. Finally, Rm is further increased so that the parameter plane location
lies within the unshaded region. The complex eigenvalues now have positive real
part, and the solution settles into a periodic orbit as seen within Figure 12.
4.3. Conclusions & Biological Implications. In the standard model of viral
dynamics both the infected and uninfected steady states are globally stable, and
thus the stability of equilibria has no dependence on the initial viral load or healthy
T-cell count of a host. The current model features a region of bistability in which
both the infection-free and persistent infection steady states are only locally stable.
Therefore, the initial conditions (along with parameter values) influence the long
time asymptotic behavior of the system. Though the healthy T-cell count at the
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Figure 11. Simulation of the dimensionless system for Rm = 9 and R0 =
1.25. The parameter location is at the border of the (dark) red and unshaded
regions of Figure 3. Hence, complex eigenvalues of the system linearized about
E+i are of the form ±iβ, signaling a transition in the asymptotic behavior of
solutions and the emergence of a stable orbit.
time of transmission has the strongest impact on the long term behavior (as shown
by Figure 8), the initial viral load also affects the ability of the virus to establish a
persistent infection. Hence, the proposed model can account for differing infection
dynamics that were displayed by clinical experiments due to variations in the initial
size of the viral inoculum or initial strength of the T-cell count. Additionally, the
model yields results that highlight the sensitivity of infection dynamics with respect
to variations in initial data. In particular, Figure 8 shows that only certain ranges
of the T-cell count promote viral infection, though their width may change with
parameter values. This contradicts the general idea that an increase in CD4 T-cells,
which serve as target cells for HIV, will necessarily give rise to a greater likelihood of
infection, since within the parameter region of bistability, increasing T0 can actually
push the system from the infected state to an uninfected regime. This result is
consistent with the clinical immunosuppressant studies of [7,15] which found that in
some cases, a depleted T-cell count could give rise to a greater possibility of infection.
Therefore, differing initial strengths of the susceptible T-cell population may either
promote or inhibit viral replication, and a “sweet spot” in the initial state (seen as
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Figure 12. Simulation of the dimensionless system for Rm = 9.25 and
R0 = 1.25. The parameters now lie within the unshaded region (Figure 3).
Complex eigenvalues of the system linearized about E+i are of the form α± iβ
with α > 0 yielding instability of the equilibrium. With initial conditions taken
near the bifurcation, a stable periodic orbit appears.
the dark strips within Figure 8) appears to exist within which infection occurs. In
general, the refined model (3CM) further highlights the biological implications of
T-cell homeostasis, namely that the propensity of the T-cell population to replenish
itself, not merely at a constant rate but due to the appearance of a pathogen, can
account for differing infection outcomes.
With the emergence of a Hopf bifurcation in (3CM), there also exists a region
of the (Rm, R0) plane within which solutions display stable oscillations, thereby
mimicking observed biological behavior such as viral blips. Such oscillatory blips
are transient spikes in the size of the viral load which often occur in a patient
undergoing antiretroviral therapy during the chronic stage of infection [28]. Various
studies have found that 20% to 60% of patients with viral suppression experience
viral load blips (depending on the antiretroviral regimen used and the frequency
of viral load testing), and perhaps one-third of these experience repeated blips.
Within the proposed model, blips can occur from a sudden, but small, change in
parameter values that increase Rm or decrease R0 from the region in which E
+
i is
stable into the region in which a periodic orbit becomes stable. Such changes in
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parameter values may realistically arise from interruption or sudden alteration of
antiretroviral therapy, which strongly influences the values of k and p in the model,
and thus the dimensionless parameters R0 and Rm, as well. Hence, (3CM) may be
extended to further explain phenomena during chronic infection when the effects of
antiretroviral therapy can drastically alter parameter values in the (Rm, R0) plane.
Finally, the proposed model can also be generalized to describe the entire time
course of infection [12, 13] by incorporating additional components and biological
effects, though a full dynamical analysis would likely be prohibitive in such a case.
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Appendix A. Dimensionless System. We begin by placing the model in non-
dimensional form. First, define the dimensionless populations by
T ∗ =
T
Tc
, I∗ =
I
Ic
, V ∗ =
V
Vc
where Tc, Ic, and Vc are constants to be determined. Additionally, we scale the time
dimension by letting t∗ = t
tc
. Substituting these expressions within (3CM), we find
dT ∗
dt∗
=
λtc
Tc
− ρtcVc
C + VcV ∗
T ∗V ∗ − ktcVcT ∗V ∗ − dT tcT ∗
dI∗
dt∗
=
ktcTcVc
Ic
T ∗V ∗ − dItcI∗
dV ∗
dt∗
=
ptcIc
Vc
I∗ − dV tcV ∗


(11)
Since a time scale must be selected, we choose tc =
1
dT
, though the choices of 1
dI
or 1
dV
are also reasonable and do not greatly alter the analysis. Next, we choose
the population scaling for the dependent variables so as to eliminate parameters in
24 REFERENCES
each equation. In particular, we choose
Tc =
dIdV
pk
, Ic =
dTdV
pk
, Vc =
dT
k
.
Removing the starred notation from the population variables for convenience, this
finally yields the dimensionless system
dT
dt
= R0 +
Rm
1 + βV
TV − TV − T
dI
dt
= α1(TV − I)
dV
dt
= α2(I − V )


where R0, Rm, α1, α2, β are given by (1).
Appendix B. Equilibria and Restrictions on Parameter Values. Within
this appendix, we consolidate results concerning equilibrium states of the model.
First, we derive all equilibrium solutions and prove Theorem 3.1.
Proof. (Theorem 3.1) Beginning with the steady system (6), we use the third equa-
tion to find I = V . Inserting this within the second equation yields
I(T − 1) = 0.
Thus, either I = 0 or T = 1. In the former case, V = 0, the first equation is exactly
T = R0, and the steady state Eu is determined. In the latter case, the first equation
yields a quadratic in V , namely
βV 2 + [β(1 −R0) + 1−Rm]V + 1−R0 = 0
upon multiplying by 1 + βV throughout. This gives rise to two different solutions
and with T = 1 and I = V , these constitute E+i and E
−
i .
Next, we derive the restrictions on parameters obtained by enforcing the condi-
tion that the computed steady states be real-valued and positive. First, we note that
the condition b2− 4ac ≥ 0 imposes the constraint that all equilibria are real-valued,
and upon simplification, is equivalent to
D2 − 2D(1 +Rm) + (1−Rm)2 ≥ 0
where D = β(1 −R0). Simplifying further, this condition becomes
[D − (1 +
√
Rm)
2][D − (1−
√
Rm)
2] ≥ 0.
Clearly, (1 +
√
Rm)
2 > (1−√Rm)2. Thus, b2 − 4ac ≥ 0 if and only if
D − (1 −
√
Rm)
2 ≤ 0 or D − (1 +
√
Rm)
2 ≥ 0
and this simplifies to the statement
R0 ≥ 1− 1
β
(1−
√
Rm)
2 or R0 ≤ 1− 1
β
(1 +
√
Rm)
2.
Because β < 1, the region in (Rm, R0) space described by R0 ≤ 1 − 1β (1 +
√
Rm)
2
contains only negative values of R0, which is not possible for positive original pa-
rameter values. Thus, we only focus on the region in which R0 ≥ 1− 1β (1−
√
Rm)
2
to ensure all equilibria possess real values.
In requiring all infected equilibrium populations to be positive, other restrictions
are needed. We consider two distinct cases. First, assume b < 0. This inequality is
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equivalent to R0 > 1 +
1
β
(1 − Rm). Hence, for E+i , we find −b+
√
b2 − 4ac ≥ 0 so
all populations of this infected steady state are positive. Contrastingly, for E−i , we
must have
√
b2 − 4ac < |b| to guarantee positive equilibria. Thus for E−i , an added
requirement is necessary, namely ac > 0, which is exactly the condition R0 < 1.
Next, assume b ≥ 0. Then, this is equivalent to R0 ≤ 1 + 1β (1 − Rm). For E+i
we must further consider two subcases, namely ac ≥ 0 and ac < 0. If ac ≥ 0,
then −b + √b2 − 4ac ≤ 0 and E+i possesses either negative or vanishing infected
T-cell and virus equilibrium populations. Instead, if ac < 0, which is equivalent to
R0 > 1, then −b+
√
b2 − 4ac > 0 and E+i has only positive equilibria. Contrastingly,
considering E−i , both the infected T-cell and virus population are nonpositive, thus
the steady state does not exist in this region. See Figure 2 for a graphical summary
of these restrictions.
To end Appendix B, we prove Lemma 4.2.
Proof. (Lemma 4.2) First, note that if R0 > 1, then the inequality is trivially
satisfied since V + > 0. Hence, we need only consider the case (E
+
1 ) within the
region of existence. From (8), we see that V + satisfies
aV
2
+ + bV + + c = 0
where a = β, b = β(1 − R0) + 1 − Rm, and c = 1 − R0. In this notation, (E+1 )
is exactly b < 0. Of course, in the region of existence of E+i , we also have V + >
0. Additionally, notice that the inequailty βV
2
+ + R0 − 1 > 0 is equivalent to
aV
2
+ − c > 0, or using the above quadratic, −bV + − 2c > 0. Since b < 0, this is
further equivalent to the inequality
V + >
2c
−b ,
and we will focus on proving this condition.
Now, if c ≤ 0, then
V + > 0 ≥ 2c−b
and the condition is satisfied. Alternatively, if c > 0 then writing the root of interest,
namely V + =
−b+√b2−4ac
2a , and multiplying by the conjugate we find
V =
2c
−b−√b2 − 4ac >
2c
−b
because b < 0, c > 0, and b2 − 4ac > 0. Hence, the condition is satisfied in both
cases, and the proof is complete.
Appendix C. Proof of Stability Theorem. Finally, we prove Theorem 4.1.
Proof. (Theorem 4.1) We first define x = (T, I, V )T , label the right side of the
system (3CM*) by f , so that
f(x) =


R0 +
(
Rm
1+βV − 1
)
TV − T
α1 (TV − I)
α2(I − V )


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and compute the gradient of this function
∇f(x) =


− 11+βV
[
βV 2 + (1 + β −Rm)V + 1
]
0
[
Rm
(1+βV )2
− 1
]
T
α1V −α1 α1T
0 α2 −α2


.
To prove the stability result concerning the uninfected steady state, we evaluate
the Jacobian at Eu to find
∇f(Eu) =


−1 0 (Rm − 1)R0
0 −α1 α1R0
0 α2 −α2


.
Clearly, the eigenvalues are η1 = −1 and η2, η3 given by the two roots of the
quadratic
η2 + (α1 + α2)η + α1α2(1−R0) = 0.
By the Routh-Hurwitz criterion, the latter eigenvalues both have negative real part
if and only if R0 < 1. Hence, we conclude by the Hartman-Grobman theorem that
Eu is locally asymptotically stable if R0 < 1. Contrastingly, if R0 > 1 then Eu is
unstable.
Next, we establish the stability properties of the infected steady states. Again,
we compute the Jacobian, but evaluate it only using the T-cell steady state value,
T = 1, as the value of the viral load differs for E+i and E
−
i . With this, we find
∇f(E±i ) =


−R0 0 Rm(1+βV ±)2 − 1
α1V ± −α1 α1
0 α2 −α2


where V ± is given by Theorem 3.1 for either steady state and, in both cases, satisfies
the quadratic
βV
2
± + [β(1 −R0) + 1−Rm]V ± + 1−R0 = 0. (12)
The associated characteristic polynomial is η3 + d2η
2 + d1η + d0 = 0 where
d0 =
α1α2V ±
(1 + βV ±)2
[−Rm + (1 + βV ±)2] ,
d1 = (α1 + α2)R0,
d2 = α1 + α2 +R0.
The Routh-Hurwitz conditions are clearly met for d1 and d2 since all parameter
values are positive. We only concern ourselves with the sign of d0 and showing the
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other remaining condition, namely D2 = d1d2−d0 > 0. After some algebra and use
of (12), we can rewrite d0 as
d0 =
α1α2
1 + βV ±
[
βV
2
± +R0 − 1
]
which means that d0 > 0 if and only if the condition
α1α2
1 + βV ±
[
βV
2
± +R0 − 1
]
> 0
is satisfied. First considering the E+i steady state, we find by Lemma 4.2 that
the above inequality holds at every point in the region of existence. To study the
condition D2 > 0, we merely note that this is equivalent to
α1α2
1 + βV +
[
βV
2
+ +R0 − 1
]
< (α1 + α2)R0(α1 + α2 +R0)
and results in (7). Thus, the condition for stability of E+i is complete.
Finally, to establish the instability of E−i in every parameter regime that guar-
antees postivity of this equilibrium, we will show that the conditions which ensure
V − > 0 in this case violate the stability criteria. It was previously shown that the
conditions b < 0, c > 0, and b2− 4ac ≥ 0 are needed in order to arrive at a positive
root V − for E−i which satisfies (12), in which case
a = β, b = β(1 −R0) + 1−Rm, c = 1−R0.
Hence, writing the root of interest, namely
V − =
−b−√b2 − 4ac
2a
,
and multiplying by the conjugate of the numerator, we find
V − =
2c
−b+√b2 − 4ac ≤
2c
−b
as b < 0, c > 0, and b2 − 4ac ≥ 0. Rewriting this inequality as bV − + c ≥ −c and
substituting parameters for b and c yields
[β(1−R0) + 1−Rm]V − + 1−R0 ≥ −(1−R0).
Using (12), this inequality is exactly
−βV 2− ≥ −(1−R0).
Rearranging finally yields the condition
βV
2
− +R0 − 1 ≤ 0,
which, considering the postivity of V − and parameters, violates the stability crite-
rion
α1α2
1 + βV ±
[
βV
2
± +R0 − 1
]
> 0,
thereby implying instability of E−i .
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